Glaukos (GKOS) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Globe and Mail, The
President and CEO — Joseph Gilliam Chief Financial Officer — Alex Thurman Vice President, Investor Relations — Christopher Lewis Need a quote from a Motley Fool analyst? Email pr@fool.com TAKEAWAYS Consolidated Net Sales -- $150.6 million with year-over-year growth of 41% on a reported basis and 39% on a constant currency basis. Updated Full-Year Net Sales Guidance -- Now $620 million to $635 million, increased from prior guidance of $600 million to $620 million. U.S. Glaucoma Franchise Sales -- $93.5 million, representing 58% year-over-year growth. iDose TR Sales -- Approximately $54 million, contributing significantly to U.S. glaucoma performance. International Glaucoma Sales -- $35.8 million, up 23% year over year on a reported basis and 16% on a constant currency basis. Corneal Health Franchise Sales -- $21.3 million, with 15% year-over-year growth; includes Fetrexan and initial Epioxa sales totaling $17.7 million. Epioxa Site of Care Network -- Devices now
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Glaukos (GKOS) Q1 2026 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
- Glaukos Announces First Quarter 2026 Financial ResultsBusiness Wire
- Glaukos Announces the Release of its 2025 Sustainability ReportBusiness Wire
- Glaukos Receives Permanent J-code for Epioxa™ [Yahoo! Finance]Yahoo! Finance
- Glaukos Receives Permanent J-code for Epioxa™Business Wire
GKOS
Earnings
- 4/29/26 - Beat
GKOS
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/29/26 - Form 8-K
- 4/29/26 - Form SCHEDULE
- GKOS's page on the SEC website